Lesley Ann Calhoun

CFO

COO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ALGS

Current role

CFO, COO

2025-01-30–present

TNGX

Current role

Board Member

2021-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Aligos Therapeutics, Inc. (ALGS)	Executive Vice President, Chief Operating Officer and Chief Financial Officer	$502,000	—	—	$874,929	$190,760	$12,000	$1,579,689
2024	Aligos Therapeutics, Inc. (ALGS)	Executive Vice President, Chief Operating Officer and Chief Financial Officer	$455,862	—	—	$361,516	$190,368	$12,000	$1,019,746

No earnings-call appearances or filed executive changes recorded yet.